ATI RN
ATI Pharmacology Practice A Questions
Question 1 of 5
Which class of targeted therapy would cause the nurse the most concern in regard to a possible infusion reaction?
Correct Answer: C
Rationale: Monoclonal antibodies, such as trastuzumab and rituximab, are more likely to cause infusion reactions compared to other classes of targeted therapy. These reactions can range from mild symptoms like fever and chills to severe anaphylaxis. Tyrosine kinase inhibitors, multikinase inhibitors, and proteasome inhibitors are less commonly associated with infusion reactions. The nurse should closely monitor patients receiving monoclonal antibodies during infusion and be prepared to manage any adverse reactions promptly.
Question 2 of 5
Selegiline:
Correct Answer: A
Rationale: Selegiline selectively inhibits MAO-B, increasing dopaminergic activity in Parkinson's disease treatment.
Question 3 of 5
A 34-year-old man with seasonal allergic rhinitis that has been refractory to oral antihistamines is now placed on Singulair, a leukotriene receptor blocker, to see if this will improve symptoms. Important interactions with this medication include which of the following?
Correct Answer: C
Rationale: Singulair (montelukast) interacts with rifampin , a CYP3A4 inducer that reduces montelukast levels, decreasing efficacy. Ampicillin , chloramphenicol , and tetracycline lack significant interactions. Rifampin's effect is key in refractory rhinitis.
Question 4 of 5
The nurse is caring for a client receiving isoniazid (INH) for tuberculosis. Which instruction should the nurse include?
Correct Answer: C
Rationale: Isoniazid treats TB but risks hepatotoxicity, causing jaundice (yellowing skin, choice
C), a serious sign needing immediate reporting to prevent liver failure. Food is optional'INH can be taken either way. Tyramine relates to MAOIs, not INH. Bedtime isn't specific'dosing is flexible. Reporting jaundice aligns with INH's side effect profile, critical in TB therapy where long-term use is common, making C the essential instruction for early detection and safety.
Question 5 of 5
When taking Nitroglycerine (transdermal), you should have how many hours nitrate free each day?
Correct Answer: D
Rationale: When using Nitroglycerine transdermal patches, it is recommended to have a nitrate-free period of at least 10-12 hours each day to prevent the development of tolerance to the medication. Continuous exposure to nitrates can lead to a decrease in efficacy over time. By having a nitrate-free interval each day, the body has a chance to "reset" and maintain the effectiveness of the medication for angina control. It is crucial to follow this dosing schedule as directed by a healthcare provider to ensure optimal benefits and reduce the risk of tolerance.